GEODE CAPITAL MANAGEMENT, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in REGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,014,838,051
+$70,080,713 QoQ
Shares Held
2,607,732
+3.5% QoQ
Ownership
2.49%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.87111405619903.ToString("F0")%
Shared 0.ToString("F0")%
None 0.12888594380097343.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,580,924,343 across 526 Biotechnology names. REGN ranks #2 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,014,838,051 | 2,607,732 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,944,757,338 | 2,519,540 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,425,859,367 | 2,535,898 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,294,153,350 | 2,465,054 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,566,284,893 | 2,469,585 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,729,273,677 | 2,427,630 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,388,691,653 | 2,272,261 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,538,605,309 | 2,415,350 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $2,287,445,071 | 2,376,591 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,067,685,248 | 2,354,217 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,909,255,678 | 2,319,986 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,639,082,431 | 2,281,129 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,822,458,308 | 2,217,993 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,593,042,705 | 2,207,990 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,543,146,642 | 2,240,113 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,308,823,297 | 2,214,104 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,461,633,121 | 2,092,771 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,248,705,759 | 1,977,302 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,053,141,498 | 1,740,212 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $953,986,320 | 1,708,000 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $761,845,296 | 1,610,190 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $766,656,437 | 1,586,919 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $983,525,622 | 1,756,986 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $948,654,594 | 1,521,133 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $650,654,725 | 1,332,517 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||